Search research articles
Contact Us
Filters
Showing results (1491-1500 of 1,873) with videos related to
Page
of 188
Sort By:
JACC. Heart Failure
|
December 9, 2023
Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper
Anuradha Lala, Carine E Hamo, Biykem Bozkurt, et al.
JAMA Cardiology
|
October 3, 2022
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
Muthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
JAMA
|
October 11, 2024
Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial
Niklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
Journal of the American College of Cardiology
|
May 24, 2023
Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection Fraction
Riccardo M Inciardi, Martin Abanda, Amil M Shah, et al.
Circulation. Heart Failure
|
April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial
Eldrin F Lewis, Brian Claggett, Amil M Shah, et al.
JAMA Cardiology
|
March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF
Misato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
JAMA Cardiology
|
June 4, 2025
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical Trial
Kirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
JACC. Heart Failure
|
April 28, 2022
Relationship of Dapagliflozin With Serum Sodium: Findings From the DAPA-HF Trial
Su Ern Yeoh, Kieran F Docherty, Pardeep S Jhund, et al.
JACC. Heart Failure
|
July 28, 2022
Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HF
Jawad H Butt, Pooja Dewan, Ersilia M DeFilippis, et al.
JACC. Heart Failure
|
April 10, 2025
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial
John W Ostrominski, Finnian R Mc Causland, Brian L Claggett, et al.
Page
of 188
Search research articles
Search
Showing results (1491-1500 of 1,873) with videos related to
Sort By:
Page
of 188
JACC. Heart Failure
|
December 9, 2023
Standardized Definitions for Evaluation of Acute Decompensated Heart Failure Therapies: HF-ARC Expert Panel Paper
Anuradha Lala, Carine E Hamo, Biykem Bozkurt, et al.
JAMA Cardiology
|
October 3, 2022
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
Muthiah Vaduganathan, Brian L Claggett, Pardeep Jhund, et al.
JAMA
|
October 11, 2024
Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial
Niklas Dyrby Johansen, Muthiah Vaduganathan, Ankeet S Bhatt, et al.
Journal of the American College of Cardiology
|
May 24, 2023
Right Ventricular Function and Pulmonary Coupling in Patients With Heart Failure and Preserved Ejection Fraction
Riccardo M Inciardi, Martin Abanda, Amil M Shah, et al.
Circulation. Heart Failure
|
April 18, 2018
Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial
Eldrin F Lewis, Brian Claggett, Amil M Shah, et al.
JAMA Cardiology
|
March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HF
Misato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
JAMA Cardiology
|
June 4, 2025
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical Trial
Kirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
JACC. Heart Failure
|
April 28, 2022
Relationship of Dapagliflozin With Serum Sodium: Findings From the DAPA-HF Trial
Su Ern Yeoh, Kieran F Docherty, Pardeep S Jhund, et al.
JACC. Heart Failure
|
July 28, 2022
Effects of Dapagliflozin According to the Heart Failure Collaboratory Medical Therapy Score: Insights From DAPA-HF
Jawad H Butt, Pooja Dewan, Ersilia M DeFilippis, et al.
JACC. Heart Failure
|
April 10, 2025
Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial
John W Ostrominski, Finnian R Mc Causland, Brian L Claggett, et al.
Page
of 188